Impact of Perioperative Proton Pump Inhibitors on Renal Cancer Progression. A Retrospective Study
Cancer Medicine · 2026-03 · 15 (3)
DOI: 10.1002/cam4.71723 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 12.03.2026. Verfasst von Nicolas Cortes-Mejia und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Wyckoff Heights Medical Center, New York City, New York, USA. Hauptthemen laut MEDLINE: Kidney Neoplasms, Carcinoma, Renal Cell, Proton Pump Inhibitors, H(+)-K(+)-Exchanging ATPase. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
Background
Clear cell renal cell carcinoma (ccRCC) is the most common kidney cancer. Metastatic disease causes most deaths. We investigated the association between ATP4A gene status and survival following nephrectomy. ATP4A encodes H + /K + ATPase, targeted by proton pump inhibitors (PPIs). We also examined how perioperative use of these drugs affects cancer progression post‐surgery.
Methods
Using a publicly available database, we employed in silico analysis to investigate the association between the ATP4A gene and recurrence‐free survival and overall survival. After receiving institutional review board approval from the University of Texas‐MD Anderson Cancer Center (#2020‐0380), we conducted a retrospective analysis to investigate the association between perioperative PPIs use and progression of nonmetastatic ccRCC. We performed a propensity score analysis and utilized inverse probability of treatment weighting to balance potential discrepancies between exposure groups. A Cox proportional hazards model, weighted by inverse probability of treatment weighting, was subsequently fitted for multivariable analysis.
Results
ATP4A gene expression analysis showed that high tumor levels were associated with a significant reduction in overall survival. The analysis included a total of 1775 patients with ccRCC. After propensity matching, the analysis revealed that the use of perioperative PPIs was not independently associated with a worse oncological prognosis following nephrectomies.
Conclusion
Elevated ATP4A gene expression correlates with reduced survival, while perioperative PPI use shows no significant impact on survival outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Wyckoff Heights Medical Center, New York City, New York, USA.
- Tilman J. Fertitta Family College of Medicine, University of Houston, Houston, Texas, USA.
- Department of Anesthesiology, Critical Care, and Pain Medicine, McGovern Medical School UT Health, Houston, Texas, USA.
- School of Medicine, Universidad de Los Andes, Bogota, Colombia.
- Transplant and Hepatobiliary Surgery Department, Fundación Santa Fe de Bogotá, Bogotá, Colombia.
- Epidemiology and Biostatistics Group, Graduate School Universidad CES, Medellín, Colombia.
ORCID-Profile: Ryan Wong, Sergio M Moreno-Lopez, Juan P Cata
Förderung
- NHLBI NIH HHS
Zitieren
APA
Cortes-Mejia, N., Wong, R., Eltzschig, H. K., Moreno-Lopez, S. M., Bejarano-Ramirez, D., Huang, H., & Cata, J. P. (2026). Impact of Perioperative Proton Pump Inhibitors on Renal Cancer Progression. A Retrospective Study. Cancer Medicine, 15(3). https://doi.org/10.1002/cam4.71723
Vancouver
Cortes-Mejia N, Wong R, Eltzschig HK, Moreno-Lopez SM, Bejarano-Ramirez D, Huang H, et al. Impact of Perioperative Proton Pump Inhibitors on Renal Cancer Progression. A Retrospective Study. Cancer Medicine. 2026;15(3). doi:10.1002/cam4.71723
BibTeX
@article{CortesMejia2026,
author = {Cortes-Mejia, Nicolas and Wong, Ryan and Eltzschig, Holger K and Moreno-Lopez, Sergio M and Bejarano-Ramirez, Diana and Huang, Huang and Cata, Juan P},
title = {Impact of Perioperative Proton Pump Inhibitors on Renal Cancer Progression. A Retrospective Study},
journal = {Cancer Medicine},
year = {2026},
volume = {15},
number = {3},
doi = {10.1002/cam4.71723}
}
EUVIMED